RESUMO
Using a metagenomic approach, we identified hepatitis A virus among cases of acute febrile illnesses that occurred in 2008-2012 in Brazil suspected as yellow fever. These findings reinforce the challenge facing routine clinical diagnosis in complex epidemiological scenarios.
Assuntos
Hepatite A/diagnóstico , Febre Amarela/diagnóstico , Brasil/epidemiologia , Genótipo , Hepatite A/epidemiologia , Vírus da Hepatite A/genética , Humanos , Metagenômica , Febre Amarela/epidemiologia , Vírus da Febre Amarela/genéticaRESUMO
BACKGROUND: Due to the populations' susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario. METHODS: Dengue suspected cases (n = 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping. RESULTS: DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with ≥4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11-15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals >65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia. CONCLUSIONS: It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.
Assuntos
Vírus da Dengue/genética , Vírus da Dengue/patogenicidade , Dengue/epidemiologia , Dengue/etiologia , Adolescente , Brasil/epidemiologia , Criança , Coinfecção/epidemiologia , Coinfecção/virologia , Vírus da Dengue/classificação , Surtos de Doenças , Feminino , Genótipo , Glicoproteínas/imunologia , Humanos , Masculino , Filogenia , Sorogrupo , Venezuela , Proteínas não Estruturais Virais/imunologia , Viremia/epidemiologiaRESUMO
This article discusses the peculiar conditions that favoured the unexpected introduction of Zika virus into the poorest northeastern region of Brazil in 2015, its speed of transmission to other Brazilian states, other Latin American countries and other regions, and the severity of related neurological disorders in newborns and adults. Contrasting with evidence that Zika had so far caused only mild cases in humans in the last six decades, the epidemiological scenario of this outbreak in Brazil indicates dramatic health effects: in 2015, an increase of 20-fold in notified cases of microcephaly and/or central nervous system (CNS) alterations suggestive of Zika congenital infection, followed by an exponential increase in 2016, with 2366 cumulative cases confirmed in the country by the end of December 2016. A significant increase in Guillain-Barré syndrome in adults has also been reported. Factors involved in viral dissemination, neural pathogenesis and routes of transmission in Brazil are examined, such as the role of social and environmental factors and the controversies involved in the hypothesis of antibody-dependent enhancement, to explain the incidence of congenital Zika syndrome in Brazil. Responses to the Zika outbreak and the development of new products are also discussed.
Assuntos
Notificação de Doenças , Surtos de Doenças , Microcefalia/virologia , Complicações Infecciosas na Gravidez/virologia , Infecção por Zika virus/transmissão , Brasil/epidemiologia , Dengue/epidemiologia , Dengue/imunologia , Feminino , Humanos , Incidência , Recém-Nascido , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Análise Espacial , Infecção por Zika virus/complicações , Infecção por Zika virus/imunologiaRESUMO
BACKGROUND: In Brazil dengue has been a major public health problem since DENV-1 introduction and spread in 1986. After a low or silent co-circulation, DENV-1 re-emerged in 2009 causing a major epidemic in the country in 2010 and 2011. In this study, the phylogeny of DENV-1 strains isolated in RJ after its first introduction in 1986 and after its emergence in 2009 and 2010 was performed in order to document possible evolutionary patterns or introductions in a re-emergent virus. FINDINGS: The analysis of the E gene sequences demonstrated that DENV-1 isolated during 2009/2010 still belong to genotype V (Americas/Africa) but grouping in a distinct clade (lineage II) of that represented by earlier DENV-1 (lineage I). However, strains isolated in 2011 grouped together forming another distinct clade (lineage III). CONCLUSIONS: The monitoring of DENV is important to observe the spread of potentially virulent strains as well to evaluate its impact over the population during an outbreak. Whether explosive epidemics reported in Brazil caused mainly by DENV-1 was due to lineage replacement, or due the population susceptibility to this serotype which has not circulated for almost a decade or even due to the occurrence of secondary infections in a hyperendemic country, is not clear. This is the first report of multiple lineages of DENV-1 detected in Brazil.
Assuntos
Vírus da Dengue/classificação , Vírus da Dengue/isolamento & purificação , Dengue/epidemiologia , Dengue/virologia , Brasil/epidemiologia , Análise por Conglomerados , Vírus da Dengue/genética , Evolução Molecular , Genótipo , Humanos , Dados de Sequência Molecular , Filogenia , RNA Viral/genética , Análise de Sequência de DNA , Proteínas do Envelope Viral/genéticaRESUMO
BACKGROUND: Rio de Janeiro (RJ) has been of major importance for the epidemiology of dengue viruses (DENVs) in Brazil. After the DENV 1-4 introductions in 1986, 1990, 2000 and 2011, respectively, the state has suffered explosive epidemics. We aimed to describe laboratorial, epidemiological and clinical aspects due to the emergence and re-emergence of distinct DENV in a 2-year period. METHODS: Suspected dengue cases (n=2833), including 190 fatal cases, were submitted to virus isolation, RT-PCR and non-structural 1 (NS1) antigen capture ELISA, IgM antibody-capture (MAC)-ELISA and IgG-ELISA. RESULTS: Case confirmation was 47.5%. MAC-ELISA confirmed 32.6% of the cases, RT-PCR confirmed 56.3%; DENV was recovered in 33.1% of samples inoculated and NS1 ELISA confirmed 27.5% of the cases. DENV-2 was prevalent in 2010, DENV-1 in 2011 and DENV-4 in 2012. Individuals infected by DENV-3 and over 65 years-old, and children 15 years-old and under infected by DENV-2 had a significantly higher risk of developing a severe disease. Fatal cases confirmed (n=67) were due to DENV-1 (26.8%), DENV-2 (14.9%), DENV-3 (2.9%) and DENV-4 (7.4%). CONCLUSIONS: It has been shown here that viral emergences or re-emergences may play different roles in the disease epidemiology, especially when many serotypes co-circulate.
Assuntos
Anticorpos Antivirais/imunologia , Vírus da Dengue/isolamento & purificação , Dengue/epidemiologia , Vigilância em Saúde Pública , Adolescente , Adulto , Brasil/epidemiologia , Criança , Pré-Escolar , Dengue/imunologia , Dengue/transmissão , Vírus da Dengue/imunologia , Surtos de Doenças , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina G/imunologia , Imunoglobulina M/imunologia , Masculino , Reação em Cadeia da PolimeraseRESUMO
Strain typing is a critical tool for molecular epidemiological analysis and can provide important information about the spread of dengue viruses. Here, we performed a molecular characterization of DEN-2 viruses isolated in Brazil during 1990-2000 from geographically and temporally distinct areas in order to investigate the genetic distribution of this serotype circulating in the country. Restriction site-specific polymerase chain reaction (RSS)-PCR presented the same pattern for all 52 Brazilian samples, showing the circulation of just one DEN-2 variant. Phylogenetic analysis using progressive pairwise alignments from 240-nucleotide sequences of the E/NS1 junction in 15 isolates showed that they belong to genotype III (Jamaica genotype).
Assuntos
Vírus da Dengue/genética , Sequência de Aminoácidos/genética , Brasil , Vírus da Dengue/classificação , Eletroforese em Gel de Ágar , Genótipo , Humanos , Filogenia , Reação em Cadeia da Polimerase , RNA Viral/análise , RNA Viral/genética , Mapeamento por RestriçãoRESUMO
OBJECTIVE: To verify if the Bio-Manguinhos 17DD yellow fever vaccine (17DD-YFV) used in lower doses is as immunogenic and safe as the current formulation. RESULTS: Doses from 27,476 IU to 587 IU induced similar seroconversion rates and neutralizing antibodies geometric mean titers (GMTs). Immunity of those who seroconverted to YF was maintained for 10 mo. Reactogenicity was low for all groups. METHODS: Young and healthy adult males (n = 900) were recruited and randomized into 6 groups, to receive de-escalating doses of 17DD-YFV, from 27,476 IU to 31 IU. Blood samples were collected before vaccination (for neutralization tests to yellow fever, serology for dengue and clinical chemistry), 3 to 7 d after vaccination (for viremia and clinical chemistry) and 30 d after vaccination (for new yellow fever serology and clinical chemistry). Adverse events diaries were filled out by volunteers during 10 d after vaccination. Volunteers were retested for yellow fever and dengue antibodies 10 mo later. Seropositivity for dengue was found in 87.6% of volunteers before vaccination, but this had no significant influence on conclusions. CONCLUSION: In young healthy adults Bio-Manguinhos/Fiocruz yellow fever vaccine can be used in much lower doses than usual. INTERNATIONAL REGISTER: ISRCTN 38082350.
Assuntos
Relação Dose-Resposta Imunológica , Vacinação/métodos , Vacina contra Febre Amarela/administração & dosagem , Vacina contra Febre Amarela/imunologia , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , Método Duplo-Cego , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/patologia , Voluntários Saudáveis , Humanos , Masculino , Fatores de Tempo , Vacinação/efeitos adversos , Vacina contra Febre Amarela/efeitos adversos , Adulto JovemRESUMO
This article discusses the peculiar conditions that favoured the unexpected introduction of Zika virus into the poorest northeastern region of Brazil in 2015, its speed of transmission to other Brazilian states, other Latin American countries and other regions, and the severity of related neurological disorders in newborns and adults. Contrasting with evidence that Zika had so far caused only mild cases in humans in the last six decades, the epidemiological scenario of this outbreak in Brazil indicates dramatic health effects: in 2015, an increase of 20-fold in notified cases of microcephaly and/or central nervous system (CNS) alterations suggestive of Zika congenital infection, followed by an exponential increase in 2016, with 2366 cumulative cases confirmed in the country by the end of December 2016. A significant increase in Guillain-Barré syndrome in adults has also been reported. Factors involved in viral dissemination, neural pathogenesis and routes of transmission in Brazil are examined, such as the role of social and environmental factors and the controversies involved in the hypothesis of antibody-dependent enhancement, to explain the incidence of congenital Zika syndrome in Brazil. Responses to the Zika outbreak and the development of new products are also discussed.
Assuntos
Feminino , Gravidez , Recém-Nascido , Complicações na Gravidez/virologia , Dengue/imunologia , Dengue/epidemiologia , Infecção por Zika virus/complicações , Infecção por Zika virus/imunologia , Infecção por Zika virus/transmissão , Microcefalia/virologia , Brasil/epidemiologia , Surtos de Doenças , Notificação de Doenças , Análise EspacialRESUMO
We have developed an indirect enzyme-linked immunosorbent assay for detection of anti-dengue virus (DENV) immunoglobulin G antibodies using four recombinant DENV envelope polypeptides as antigens, which demonstrated a sensitivity of 89.4% and a specificity of 93.3%. These easily produced antigens are a feasible, cost-effective alternative for generating reagents for dengue serological tests.
Assuntos
Anticorpos Antivirais/sangue , Antígenos Virais/imunologia , Dengue/diagnóstico , Ensaio de Imunoadsorção Enzimática/métodos , Proteínas Recombinantes/imunologia , Dengue/sangue , Dengue/imunologia , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Sensibilidade e EspecificidadeRESUMO
Vírus dengue tipo 1 foi isolado em cultura de células de Aedes albopictus, do soro de pacientes oriundos no município de Nova Iguaçu, RJ. O quadro clínico caracterizou-se por febre, cefaléia, dor retro-orbitária, mialgias, articulares e prostração. A análise de soros pareados confirmou a presença de infecção recente por dengue tipo 1. A epidemia expandiu-se para áreas próximas, inclusive a cidade do Rio de Janeiro (maio, 1986).
RESUMO
Os autores apresentam dados obtidos no estudo de soros com a finalidade de determinar os níveis de anticorpos para rubéola, no período de 1970 a 1975, na cidade do Rio de Janeiro. Estes soros induiram principalmente gestantes em contato com casos clínicos ou suspeitos de rubéola. Dentre as gestantes, de 2.155 casos em que as informações eram mais completas, analisaram-se os resultados da sorologia com a finalidade de estabelecer o grau de imunidade prévio ao contato e o nível de risco para o concepto. Verificou-se que 84,4% destas gestantes possuiam anticorpos, sendo que destas 8,1% alcançaram níveis iguais ou superiores a 1/320, sugerint infecção recente. Obteve-se conversão sorológica em 1,2%, comprovando-se a infecção atual por rubéola. A análise dos dados referentes a casos notificados de rubéola na cidade do Rio de Janeiro no período de 1965 a 1974 demonstrou uma incidência maior no segundo semestre, tendo ocorrido dois surtos da doença, um em 1968 e outro em 1974.